The article provides a practical review of the 2012 ACCP guidelines for managing VTE and antithrombotic therapy in pregnant women using clinical case analyses.
Case-based review of 2012 ACCP VTE guidelines may aid pregnancy management decisions; leaves open need for updated evidence synthesis.
Summary The American College of Chest Physicians (ACCP) published its latest (9th edition) guidelines in February 2012. This document is a valuable reference for all clinicians. In the current article, through the analysis of three clinical cases, the authors review, describe, and analyze the most significant new information from the chapter “VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy”: (1) strategies for clinicians facing the prescription of a new drug during pregnancy with little available data; (2) recommendations about indications of thromboprophylaxis for asymptomatic thrombophilias; and (3) thrombophilia screening and secondary prevention for placental complications.
No takes yet. Share an insight, caveat, or question.
Nadine Sauvé (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: